Fig. 1From: Noninvasive imaging signatures of HER2 and HR using ADC in invasive breast cancer: repeatability, reproducibility, and association with pathological complete response to neoadjuvant chemotherapyThe study workflow showing the discovery and validation stepsBack to article page